1 ML certolizumab pegol 200 MG/ML Prefilled Syringe [Cimzia]
- RxCUI
- 849599
- RxNorm name
- 1 ML certolizumab pegol 200 MG/ML Prefilled Syringe [Cimzia]
- Display name
- 1 ML certolizumab pegol 200 MG/ML Prefilled Syringe [Cimzia]
- Full name
- 1 ML certolizumab pegol 200 MG/ML Prefilled Syringe [Cimzia]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:17
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125160 | Cimzia | certolizumab pegol | 351(a) | Rx | 2026-10-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b4c2c9dc-a0bb-4d64-a667-a67ebe88392d | Cimzia 200 MG in 1 ML Prefilled Syringe [PSN] · 1 ML certolizumab pegol 200 MG/ML Prefilled Syringe [Cimzia] [SBD] · 1ML Cimzia 200 MG/ML Prefilled Syringe [SY] · Cimzia 200 MG per 1 ML Prefilled Syringe [SY] | 4 | 47 | These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA. CIMZIA (certolizumab pegol) for injection, for subcutaneous use CIMZIA (certolizumab pegol) injection, for subcutaneous use Initial U.S. Approval: 2008 | 20260224 |